Zohar S - Search Results

1

A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.

Lévy V, Zohar S, Bardin C, Vekhoff A, Chaoui D, Rio B, Legrand O, Sentenac S, Rousselot P, Raffoux E, Chast F, Chevret S, Marie JP. Lévy V, et al. Among authors: zohar s. Br J Cancer. 2006 Aug 7;95(3):253-9. doi: 10.1038/sj.bjc.6603265. Epub 2006 Jul 18. Br J Cancer. 2006. PMID: 16847470 Free PMC article. Clinical Trial.

2

Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial.

Duputel B, Stallard N, Montestruc F, Zohar S, Ursino M. Duputel B, et al. Among authors: zohar s. Stat Methods Med Res. 2023 May;32(5):963-977. doi: 10.1177/09622802231160554. Epub 2023 Mar 15. Stat Methods Med Res. 2023. PMID: 36919403 Free PMC article. Clinical Trial.

3

Alternate designs for conduct and analysis of phase I cancer trials.

Lévy V, Zohar S, Porcher R, Chevret S. Lévy V, et al. Among authors: zohar s. Blood. 2001 Aug 15;98(4):1275-6. doi: 10.1182/blood.v98.4.1275. Blood. 2001. PMID: 11510472 Free article. No abstract available.

4

The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies.

Zohar S, Chevret S. Zohar S, et al. Stat Med. 2001 Oct 15;20(19):2827-43. doi: 10.1002/sim.920. Stat Med. 2001. PMID: 11568943

5

Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.

Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, Hachulla E, Philippe P, Sibilia J, Rabian C, Chevret S, Gluckman E; Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group. Farge D, et al. Among authors: zohar s. Br J Haematol. 2002 Dec;119(3):726-39. doi: 10.1046/j.1365-2141.2002.03895.x. Br J Haematol. 2002. PMID: 12437652 Free article. Clinical Trial.

6

Phase I (or phase II) dose-ranging clinical trials: proposal of a two-stage Bayesian design.

Zohar S, Chevret S. Zohar S, et al. J Biopharm Stat. 2003 Feb;13(1):87-101. doi: 10.1081/BIP-120017728. J Biopharm Stat. 2003. PMID: 12635905

7

Software to compute and conduct sequential Bayesian phase I or II dose-ranging clinical trials with stopping rules.

Zohar S, Latouche A, Taconnet M, Chevret S. Zohar S, et al. Comput Methods Programs Biomed. 2003 Oct;72(2):117-25. doi: 10.1016/s0169-2607(02)00120-7. Comput Methods Programs Biomed. 2003. PMID: 12941516 Review.

8

Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.

Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM. Desfrere L, et al. Among authors: zohar s. J Clin Pharm Ther. 2005 Apr;30(2):121-32. doi: 10.1111/j.1365-2710.2005.00630.x. J Clin Pharm Ther. 2005. PMID: 15811164 Clinical Trial.

9

Minimum effective dose of midazolam for sedation of mechanically ventilated neonates.

Treluyer JM, Zohar S, Rey E, Hubert P, Iserin F, Jugie M, Lenclen R, Chevret S, Pons G. Treluyer JM, et al. Among authors: zohar s. J Clin Pharm Ther. 2005 Oct;30(5):479-85. doi: 10.1111/j.1365-2710.2005.00678.x. J Clin Pharm Ther. 2005. PMID: 16164495 Clinical Trial.

10

Experimental designs for phase I and phase I/II dose-finding studies.

O'Quigley J, Zohar S. O'Quigley J, et al. Among authors: zohar s. Br J Cancer. 2006 Mar 13;94(5):609-13. doi: 10.1038/sj.bjc.6602969. Br J Cancer. 2006. PMID: 16434987 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters